In just two months, pharmaceuticals entering the US pharma supply chain through drug manufacturers will be serialized according to the Drug Supply Chain Security Act (DSCSA). It’s already been a long journey, but this is only the beginning. Companies can’t even take a break. In just one year the wholesale distributor saleable returns requirement will force manufacturers to either capture aggregation data or connect to a Verification Router Service (VRS)—or both! The year after that, Continue reading Sponsored: From Serialization to Full Traceability: 2018 Outlook On Compliance
This week, IQPC released the final report of a very interesting survey they conducted in April through June this year. The results are fresh and they paint a picture with good news, and not so good news about the readiness of pharmaceutical manufacturers facing serialization deadlines in the United States, the European Union and elsewhere. The survey focused on serialization planning, implementation progress, traceability in operation and benefits beyond compliance. You can download the full report here, but let’s take a look at the responses to just one of the questions they asked. Continue reading Sponsored: How Long Until You Are Fully Serialized?
The 4th Pharmaceutical Traceability Forum will occur on November 30 through December 2 in Philadelphia. Two of the top speakers will be Matt Sample, Senior Director, Secure Supply Chain from AmerisouceBergen, one of the “Big-3” wholesale distributors in the United States, and Christopher Howell, Senior Director, Global Engineering and Technology from Patheon, one of the largest pharma contract manufacturers in the U.S.. Recently, IQPC conducted an interview of both of these supply chain thought leaders. Get a copy of the interviews here. Continue reading Sponsored: Interview With Two Pharma Supply Chain Thought Leaders
Do you know what situation your peers’ businesses are in, and what they’re working to? To find out just that, IQPC polled their network of pharmaceutical serialization professionals and got responses from representatives of over 20 companies.
The results? Most find data storage and management to be their biggest issue, citing ERP systems as some of their biggest investments in 2016 and going forward. It follows that over 50% of those we polled are either implementing their strategies in multiple sites or already done and thinking beyond compliance.
IQPC also asked about their biggest inhibitors, their current and future budgets, and their experience with international compliance. If you want to find out what your peers think about these topics, you can download the survey report, or meet them on-site at the Pharmaceutical Traceability Forum, May 23 – 25 in Philadelphia. Use the discount code PT_RXTRACE to get 20% off the standard price! Continue reading Sponsored: Tracking Serialization: 2016 Pharma Trace Market Trends